Public Health Gibraltar Logo

MenB Vaccination Update

Updated: 2 October 2026

Public Health Gibraltar and the Gibraltar Health Authority (GHA) introduced a MenB catch-up vaccination programme in August 2026 for eligible students travelling abroad for university or further education.

The programme includes eligible students starting their studies and those returning to university.

Second dose appointments

University students who received their first dose of the MenB vaccine in Gibraltar and have not yet received their second dose can arrange an appointment with the GHA vaccination team.

Students returning to Gibraltar during reading week, university holidays or the Christmas period are encouraged to contact the vaccination team to arrange their second dose.

To request an appointment, please call 20003351.

Appointments are being arranged as requests are received.

Please note that the UK’s MenB vaccination programme has different eligibility criteria. Students already in their second or subsequent year of university may not be eligible to receive their second dose through the NHS.

Further information:

March 2026: Meningitis outbreak information

The information below relates to the meningococcal disease outbreak reported in Canterbury, Kent, in March 2026. It provides a record of the public health advice issued at that time.

For information about the subsequent MenB catch-up vaccination programme for Gibraltar students, please refer to the October update above.

Status Summary (31 March 2026)
  • No confirmed or suspected cases in Gibraltar at the time of this assessment.
  • Overall risk to the public was assessed as LOW.
  • Vaccination was advised for specific groups in response to the outbreak.

Historical assessment: 31 March 2026

This summary reflects the situation at the time of publication and should not be interpreted as a new assessment dated October 2026.

Since 13 March 2026, an outbreak of meningococcal disease in Canterbury, Kent, UK, had identified around 20 cases involving the bacterial meningococcal B strain.

At the time of the March update, no new cases had been identified in Kent for over a week.

Public Health Gibraltar was working closely with UK colleagues to obtain information about the outbreak.

At the time of writing in March 2026, there were no confirmed or suspected cases of meningitis in Gibraltar. The public health risk assessment was low, and MenB vaccination was not required for the wider public as a response to that outbreak.

Vaccination advice during the March 2026 outbreak

The following advice was issued in response to the Canterbury outbreak. It is retained here for historical reference and is separate from Gibraltar’s subsequent MenB catch-up vaccination programme.

Vaccination was advised for individuals who:

  • Were studying in Kent or Canterbury and identified as eligible under the outbreak response.
  • Were contacts of a confirmed or probable case in the Kent outbreak.
  • Had attended the affected nightclub, Club Chemistry, between 23 February and 15 March 2026, in accordance with the outbreak vaccination advice.

At that time, vaccination in response to the outbreak was not routinely advised for members of the general public, including those attending other UK universities, without a specific exposure risk.

This historical advice does not replace the eligibility criteria for Gibraltar’s MenB catch-up vaccination programme introduced in August 2026.

For current programme information, please consult the MenB Vaccination FAQs

Information for students in Kent and Canterbury

As part of the March outbreak response, the GHA offered MenB vaccination to Gibraltar students at Canterbury Christ Church University and the University of Kent.

Students who require their second MenB dose following vaccination in Gibraltar should now contact the GHA vaccination team on 20003351 to arrange an appointment.

Further information about the Gibraltar catch-up vaccination programme is available through the links at the top of this page.

Meningococcal Vaccination

There are two different vaccines used to protect against meningococcal disease. They protect against different groups of the bacteria.

MenACWY vaccine

This vaccine protects against meningococcal groups A, C, W and Y.

It is routinely offered to teenagers and university students, particularly before starting university, as the risk of meningococcal infection can increase where people live closely together, such as in student accommodation.

MenB vaccine

This vaccine protects against meningococcal group B.

It was introduced into the Gibraltar childhood immunisation programme in 2015 and is routinely given to infants at 2, 3 and 13 months of age.

The childhood vaccination programme provides protection against meningococcal group B disease. However, many current university students were not eligible when the programme was introduced and may remain unprotected.

In August 2026, Gibraltar introduced a separate MenB catch-up vaccination programme for eligible students travelling abroad for further education.

Students who received their first dose through this programme and require their second dose should contact the GHA vaccination team on
20003351.

Anyone concerned about their vaccination status should speak to their GP or healthcare provider.

How meningitis can spread

Meningococcal disease can spread through respiratory droplets and saliva during close or prolonged contact, such as kissing, or living in the same household or accommodation.

When should you seek medical advice?

Symptoms of meningitis or septicaemia may include:

  • Rash that does not fade when pressed.
  • Fever.
  • Severe headache.
  • Vomiting.
  • Sensitivity to light.
  • Neck stiffness.
  • Confusion or unusual drowsiness.
  • Cold hands and feet.

Symptoms can develop rapidly and may appear in any order.

Do not wait for a rash to appear.

Anyone suspected of having meningitis or septicaemia requires urgent medical attention.

In Gibraltar, call 111 for urgent medical advice. In a life-threatening emergency, call 190.

General public health advice

The following advice was issued in relation to the March 2026 outbreak:

  • Vaccination in response to the outbreak was not required for individuals outside the identified risk groups.
  • There was no advice to avoid public places or gatherings.
  • There were no travel restrictions related to the outbreak.

These statements describe the public health position in March 2026 and are separate from the subsequent MenB catch-up vaccination programme.

Vaccine enquiries

For appointments for a second MenB vaccination under the Gibraltar catch-up programme, please call
20003351.

If you are concerned about your vaccination history or require clinical advice, please contact your GP or healthcare provider.

For information about the programme, please consult the MenB Vaccination FAQs

For further information about the original catch-up programme announcement, visit the MenB Catch-up Vaccination Programme page

Skip to content
Gibraltar Health Authority Logo Close Icon